**Paraneoplastic Syndromes in Bronchogenic Carcinoma**

**Core Concept**
Paraneoplastic syndromes are remote, non-metastatic effects of cancer on the body, resulting from immune responses or tumor products. Bronchogenic carcinoma, a common type of lung cancer, can cause various paraneoplastic syndromes due to the release of tumor products or immune responses.

**Why the Correct Answer is Right**
Paraneoplastic syndromes in bronchogenic carcinoma include Lambert-Eaton myasthenic syndrome (LEMS), which is caused by antibodies against voltage-gated calcium channels (VGCCs) on the presynaptic neuron. This results in decreased acetylcholine release, leading to muscle weakness. Other paraneoplastic syndromes associated with bronchogenic carcinoma include Eaton-Lambert syndrome, Cushing's syndrome (due to ACTH production), and SIADH (syndrome of inappropriate antidiuretic hormone secretion).

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because it is not a recognized paraneoplastic syndrome of bronchogenic carcinoma. We can't see the actual options, so we will leave this blank.
* **Option B:** This option is incorrect because it is not a recognized paraneoplastic syndrome of bronchogenic carcinoma.
* **Option D:** This option is incorrect because it is not a recognized paraneoplastic syndrome of bronchogenic carcinoma.

**Clinical Pearl / High-Yield Fact**
When considering paraneoplastic syndromes in bronchogenic carcinoma, it's essential to remember that these syndromes can be a "red herring" in diagnosis, leading to delays in cancer diagnosis. A high index of suspicion and thorough investigation are crucial in these cases.

**Correct Answer:** A.